Literature DB >> 1515981

Serum cholesterol level, body mass index, and the risk of colon cancer. The Framingham Study.

B E Kreger1, K M Anderson, A Schatzkin, G L Splansky.   

Abstract

BACKGROUND: Some studies have linked low serum cholesterol levels to increased risk of colon cancer, particularly in men. Results have been inconsistent, with preclinical disease frequently offered to explain any apparent association.
METHODS: The Framingham Study cohort of 5209 persons, initially 30-62 years of age and observed more than 30 years, was evaluated. Baseline data included lipoprotein fractions, total cholesterol levels, body mass index, alcohol intake, and cardiovascular risk variables such as cigarette smoking, hypertension, and glucose intolerance.
RESULTS: In this population, colon cancer in men is related inversely to serum cholesterol levels, even when the first 10 years of follow-up are eliminated to reduce the effect of preclinical disease. This effect is concentrated in the Svedberg 0-20 fraction, corresponding to low-density lipoprotein levels. Another finding only in men is the direct relation of body mass index to colon cancer incidence.
CONCLUSIONS: Combined initial low serum cholesterol levels and obesity appear to indicate a four times greater risk for colon cancer in men as compared with people with average values of both variables. The reasons for these observations are unknown.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1515981     DOI: 10.1002/1097-0142(19920901)70:5<1038::aid-cncr2820700505>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

Review 1.  Obesity as a risk factor for certain types of cancer.

Authors:  K K Carroll
Journal:  Lipids       Date:  1998-11       Impact factor: 1.880

2.  Body mass index and adenomas of the sigmoid colon in Japanese men.

Authors:  S Kono; K Shinchi; K Imanishi
Journal:  Eur J Epidemiol       Date:  1996-08       Impact factor: 8.082

3.  Effect of cholesterol levels on villous histology in colonic adenomas.

Authors:  J Houghton; G G Lardieri; N P Zauber; K H Kim; G Cable
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

4.  Functional polymorphisms to modulate luminal lipid exposure and risk of colorectal cancer.

Authors:  Ikuko Kato; Susan Land; Adhip P Majumdar; Jill Barnholtz-Sloan; Richard K Severson
Journal:  Cancer Epidemiol       Date:  2010-03-21       Impact factor: 2.984

5.  CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection.

Authors:  Ryuma Tokunaga; Yasuo Sakamoto; Shigeki Nakagawa; Mayuko Ohuchi; Daisuke Izumi; Keisuke Kosumi; Katsunobu Taki; Takaaki Higashi; Yuji Miyamoto; Naoya Yoshida; Eiji Oki; Masayuki Watanabe; Hideo Baba
Journal:  Int J Colorectal Dis       Date:  2016-10-10       Impact factor: 2.571

6.  Serum lipids and left-sided adenomas of the large bowel: an extended study of self-defense officials in Japan.

Authors:  S Kono; K Imanishi; K Shinchi; F Yanai
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

7.  Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma.

Authors:  Sebahat Basyigit; Metin Uzman; Ayse Kefeli; Ferdane Pirincci Sapmaz; Abdullah Ozgür Yeniova; Yasar Nazligul; Zeliha Asiltürk
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Environmental factors affect colon carcinoma and rectal carcinoma in men and women differently.

Authors:  Shigeyuki Nakaji; Takashi Umeda; Tadashi Shimoyama; Kazuo Sugawara; Ken Tamura; Shinsaku Fukuda; Juichi Sakamoto; Stefano Parodi
Journal:  Int J Colorectal Dis       Date:  2003-04-15       Impact factor: 2.571

9.  Lipid profile in leukemia and Hodgkin's disease.

Authors:  P P Naik; M S Ghadge; A S Raste
Journal:  Indian J Clin Biochem       Date:  2006-09

10.  Insig2 is associated with colon tumorigenesis and inhibits Bax-mediated apoptosis.

Authors:  Chang Gong Li; Mike Gruidl; Steven Eschrich; Susan McCarthy; Hong-Gang Wang; Mark G Alexandrow; Timothy J Yeatman
Journal:  Int J Cancer       Date:  2008-07-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.